{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:35:30Z","timestamp":1791563730631,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.oret.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T21:24:16Z","timestamp":1684963456000},"page":"1027-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Individual and Systems-Based Risk Factors for Diabetic Vitrectomy in an Urban Safety-Net Hospital"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-2421","authenticated-orcid":false,"given":"Paul S.","family":"Micevych","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0486-4636","authenticated-orcid":false,"given":"Abu M.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aunoy","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-3423","authenticated-orcid":false,"given":"Jay M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2023.05.014_bib1","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","article-title":"Important causes of visual impairment in the world today","volume":"290","author":"Congdon","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2023.05.014_bib2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/dc15-2171","article-title":"Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analyses from 1990 to 2010","volume":"39","author":"Leasher","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.05.014_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.05.014_bib4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/09286580802435179","article-title":"Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population","volume":"15","author":"Lim","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.oret.2023.05.014_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","article-title":"Rationale and application of the protocol S anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.05.014_bib6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ophtha.2019.08.010","article-title":"Panretinal photocoagulation for diabetic retinopathy in the RIDE and RISE trials: not \u201c1 and done\u201d","volume":"128","author":"Gonzalez","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.05.014_bib7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Writing Committee for the Diabetic Retinopathy Clinical Research Network. Panretinal photocoagulation vs intravenous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2023.05.014_bib8","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2023.05.014_bib9","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2023.05.014_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2016.12.005","article-title":"Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab","volume":"124","author":"Bressler","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.05.014_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93384-5","article-title":"Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation","volume":"11","author":"Baek","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2023.05.014_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4103\/ijo.IJO_1217_18","article-title":"Current management of diabetic tractional retinal detachments","volume":"66","author":"Stewart","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/09286586.2014.906628","article-title":"Rate of diabetic vitrectomy in a defined geographical part of North East England","volume":"21","author":"Vaideanu","year":"2014","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.oret.2023.05.014_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11892-021-01396-2","article-title":"Management of complications and vision loss from proliferative diabetic retinopathy","volume":"21","author":"Crabtree","year":"2021","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.oret.2023.05.014_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.oret.2021.02.003","article-title":"Cost analysis of routine vitrectomy surgery","volume":"5","author":"Berkowitz","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.05.014_bib16","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ophtha.2018.02.038","article-title":"Cost evaluation of early vitrectomy versus panretinal photocoagulation and intravitreal ranibizumab for proliferative diabetic retinopathy","volume":"125","author":"Lin","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.05.014_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00055735-200106000-00016","article-title":"The cost-effectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathy","volume":"12","author":"Sharma","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib18","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2337\/dc21-0228","article-title":"Incidence of proliferative diabetic retinopathy and other neovascular sequelae at 5 years following diagnosis of type 2 diabetes","volume":"44","author":"Gange","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.05.014_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40942-016-0047-6","article-title":"Risk factors for diabetic retinopathy: a case-control study","volume":"2","author":"Lima","year":"2016","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2023.05.014_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/aos.12249","article-title":"Diabetic vitrectomy in a large type 1 diabetes patient population: long-term incidence and risk factors","volume":"92","author":"Ostri","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/dme.12628","article-title":"Long-term incidence of vitrectomy and associated risk factors in young Danish patients with type 1 diabetes: the Danish Cohort of Paediatric Diabetes 1987","volume":"32","author":"Broe","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.oret.2023.05.014_bib22","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/dc12-0790","article-title":"Predicting development of proliferative diabetic retinopathy","volume":"36","author":"Harris Nwanyanwu","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.05.014_bib23","first-page":"233","article-title":"Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18","volume":"39","author":"Davis","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2023.05.014_bib24","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/diacare.21.8.1230","article-title":"Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.05.014_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/diacare.22.3.403","article-title":"Racial and ethnic differences in glycemic control of adults with type 2 diabetes","volume":"22","author":"Harris","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2023.05.014_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001387","article-title":"Socioeconomic deprivation and development of diabetic retinopathy in patients with type 1 diabetes mellitus","volume":"8","author":"Alvarez-Ramos","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.oret.2023.05.014_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1258\/jms.2008.008013","article-title":"Diabetic retinopathy and socioeconomic deprivation in Gloucestershire","volume":"15","author":"Scanlon","year":"2008","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.oret.2023.05.014_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajo.2020.03.023","article-title":"Predictors of lost to follow-up in patients being treated for proliferative diabetic retinopathy","volume":"216","author":"Green","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajo.2020.03.011","article-title":"Loss to follow-up among patients with proliferative diabetic retinopathy in clinical practice","volume":"215","author":"Suresh","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib30","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","article-title":"Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections","volume":"125","author":"Obeid","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.05.014_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001154","article-title":"Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting","volume":"8","author":"Bresnick","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.oret.2023.05.014_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2020.09.051","article-title":"Impact and characterization of delayed panretinal photocoagulation in proliferative diabetic retinopathy","volume":"223","author":"Ohlhausen","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/eye.2016.56","article-title":"Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?","volume":"30","author":"Negretti","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2023.05.014_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaophthalmol.2022.4942","article-title":"Association of treatment type and loss to follow-up with tractional retinal detachment in proliferative diabetic retinopathy","volume":"141","author":"Tsui","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.05.014_bib35","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.5888\/pcd13.160221","article-title":"Integrating social determinants of health with treatment and prevention: a new tool to assess local area deprivation","volume":"13","author":"Maroko","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.oret.2023.05.014_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9178","article-title":"Association of socioeconomic status and infarct volume with functional outcome in patients with ischemic stroke","volume":"5","author":"Ghoneem","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.oret.2023.05.014_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.oret.2020.01.016","article-title":"Neighborhood deprivation and adherence to initial diabetic retinopathy screening","volume":"4","author":"Yusuf","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.05.014_bib38","article-title":"Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2023.05.014_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.oret.2019.03.007","article-title":"A\u00a0novel hybrid fixed and mobile ultra-widefield imaging program for diabetic teleretinopathy screening","volume":"3","author":"Afshar","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.05.014_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.oret.2019.01.013","article-title":"Improved outcomes in patients with retinal detachment after implementation of a silicone oil registry and phone call reminder system","volume":"3","author":"Ma","year":"2019","journal-title":"Ophthalmol Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:32:47Z","timestamp":1762853567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653023002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2468653023002257"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2023.05.014","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual and Systems-Based Risk Factors for Diabetic Vitrectomy in an Urban Safety-Net Hospital","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}